Skip to main content
OpenTrials
Completed

NCT Number: NCT02123069

Vascular Function and Uterine Fibroids

The purpose of this study is to learn how uterine fibroids may be connected to heart disease and high blood pressure. It is not known what causes fibroids, but they frequently occur in women who also have high blood pressure, heart disease, and stroke. The investigators of this study want to learn if certain changes in the blood vessels or nerve activity can put women at risk for these diseases and for fibroids.

Completed

Looking for future studies?

Notify Me

Key information

Age range

25 year–50 year

Sex eligibility

Female

Study type

Observational

Primary location

Mayo Clinic

Rochester, Minnesota, 55905, United States

About this study

The investigators are inviting women, 25-50 years old, who have not gone through menopause to participate in this study. The investigators are looking for some women with uterine fibroids and some without uterine fibroids based on ultrasound or MRI. If the patients have not had a recent ultrasound or MRI of the uterus, a physician can provide one.

Individuals cannot participate if they have high blood pressure, diabetes, or disease in the kidneys, lungs, or blood vessels. Also, individuals who smoke, have high cholesterol, or are obese (BMI is higher than 30) cannot participate. Certain medications, including high blood pressure medications, beta-blockers and anti-depressants, will also limit potential patient participation. The investigators would be happy to review medications for potential participants.

Screen Day:

One of the members of the research team will review the study and the informed consent document with the patient. The patient will have their height, weight, blood pressure, pulse and respirations measured. The patient will also complete three questionnaires. If the patient has not had an ultrasound of the uterus in the last 12 months, a physician will complete one for her.

Study Day:

The patient will need to fast overnight (no eating or drinking). The investigators will draw a blood sample and then do a series of tests on the participant's blood vessels. For some of the tests, medication will be given through an IV. The investigators will also test nerve activity in the nerve on the outer aspect of the leg.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Women 25-50 years old
  • Premenopausal

Exclusion criteria

  • Postmenopausal
  • Pregnant or currently breastfeeding
  • Using blood pressure medications or anti-depression medications
  • High blood pressure
  • Diabetes
  • Disease in the kidneys, lungs, or blood vessels
  • Chronic diseases (for example: Crohn's disease, rheumatoid arthritis, bipolar mood disorder, etc.)
  • Smoker
  • High cholesterol
  • BMI higher than 30

Treatment and study plan

Brachial artery catheter

Device

A catheter will be placed in the brachial artery by a physician on the study day.

Acetylcholine

Drug

Acetylcholine will be infused into the brachial catheter while blood flow levels in the forearm are measured. Acetylcholine will be infused at the following doses: 1.0, 2.0, 4.0, and 8.0 ug/100 ml tissue/min for 2 minutes each.

nitroprusside

Drug

Nitroprusside will be infused into the brachial catheter while blood flow levels in the forearm are measured. Nitroprusside will be infused at the following doses: 0.25, 0.5, 1.0, and 2.0 ug/100 ml tissue/min for 2 minutes each.

norepinephrine

Drug

Norepinephrine will be infused into the brachial catheter while blood flow levels in the forearm are measured. Norepinephrine will be infused at the following doses: 1.0, 2.0, 4.0, and 8.0 ug/100 ml tissue/min for 2 minutes each.

Nitroprusside and phenylephrine

Drug

A single dose of nitroprusside (100 ug) will be infused through an IV; one minute later, a single dose of phenylephrine (150 ug) will be infused.

Primary outcomes

  1. Baseline systolic, diastolic, and mean blood pressures

    Time frame: One day (study day)

  2. Baseline sympathetic nerve activity

    Time frame: One day (study day)

    Nerve "burst" activity will be measured across 10 minutes.

Secondary outcomes

  1. Changes in forearm blood flow levels in response to acetylcholine infusion

    Time frame: One day (study day)

  2. Changes in forearm blood flow levels in response to nitroprusside infusion

    Time frame: One day (study day)

  3. Changes in forearm blood flow levels in response to norepinephrine infusion

    Time frame: One day (study day)

  4. Change in blood pressure in response to infusions of nitroprusside and phenylephrine

    Time frame: One day (study)

    An infusion of nitroprusside will be given, followed by an infusion of phenylephrine one minute later.

  5. Pulse wave velocity (an index of vessel stiffness)

    Time frame: One day (study day)

Other outcomes

  1. Female sex hormone levels

    Time frame: One day (study day)

    Blood samples will be collected to measure levels of estrogen and progesterone.

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Registry information

Official study title

Sympathetic Nerve Activity and Vascular Function in Women With Uterine Leiomyomata

Important dates

Study start
2013
Primary completion
2018
Study completion
2018
First posted
Apr 25, 2014
Registry last updated
Mar 2, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.